Know Cancer

or
forgot password

    • cancer clinical trials in massachusetts

    • Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Waldenstrom's Macroglobulinemia, Lymphoplasmacytic Lymphoma
    Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Hepatocellular Carcinoma
    Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Biliary Tract Cancer, Gallbladder Adenocarcinoma
    Therapy for Pediatric Hodgkin Lymphoma
    Massachusetts General Hospital

    Trial Locations
    Massachusetts General Hospital
    Dana Farber Cancer Institute
    Hodgkin Lymphoma
    Preoperative Herceptin and Navelbine for Breast Cancer
    Massachusetts General Hospital

    Trial Locations
    Massachusetts General Hospital
    Dana-Farber Cancer Center
    Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer
    Capecitabine in Women With Operable Breast Cancer
    Faulkner Hospital
    Jamaica Plain, Massachusetts 02130
    Invasive Breast Carcinoma, Primary Invasive Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer
    Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
    Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Non-Hodgkin's Lymphoma
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Lahey Clinic Medical Center

    Trial Locations
    Lahey Clinic Medical Center
    Fallon Clinic Hematology/ Oncology
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
    Dana-Farber Cancer Center
    Boston, Massachusetts 02115
    Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Multiple Myeloma
    Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Early-Stage Breast Cancer
    Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Hodgkin's Disease, Breast Cancer
    Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Adenocarcinoma of Esophagus, Squamous Cell Carcinoma of Esophagus
    Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Pleural Mesothelioma, Malignant Pleural Mesothelioma
    Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
    Brigham and Women's Hospital
    Boston, Massachusetts 02115
    Pleural Mesothelioma, Malignant Pleural Mesothelioma
    The Genetics of Polycystic Ovarian Syndrome
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Polycystic Ovary Syndrome
    An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis
    Dana Faber Institute
    Boston, Massachusetts 02115
    Philadelphia Positive Chronic Myeloid Leukemia in Myeloid Blast Crisis
    An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
    Dana Faber Cancer Institute
    Boston, Massachusetts 02115
    Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
    Dana Faber Cancer Institute
    Boston, Massachusetts 02115
    Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Lahey Clinic
    Hampshire Gastroenterology
    Fallon Clinic
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    Neurosurgical Use of Interstitial Laser Therapy (ILT)
    Brigham & Women's Hospital
    Boston, Massachusetts 02115
    Brain Tumor
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    New England Medical Center

    Trial Locations
    New England Medical Center
    Dana Farber/ Harvard Cancer Center
    Lymphoma, T-Cell, Peripheral
    Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Massachusetts General Hospital
    Stomach Cancer, Gastric Cancer, Gastro-esophageal Junction Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Commonwealth Hematology Oncology PC-Concord

    Trial Locations
    Commonwealth Hematology Oncology PC-Concord
    Commonwealth Hematology Oncology PC-Haverhill
    Commonwealth Hematology Oncology PC-Lawrence
    Saints Memorial Medical Center
    Lawrence Memorial
    Holy Family Hospital
    Norwood Hospital
    Commonwealth Hematology Oncology PC-Quincy
    Commonwealth Hematology Oncology PC-Stoneham
    Commonwealth Hematology Oncology PC-Weymouth
    University of Massachusetts Medical School
    Commonwealth Hematology Oncology PC-Worcester
    Saint Vincent Hospital/Reliant Medical Group
    Adenocarcinoma of the Colon, Stage II Colon Cancer